Chevron is expanding its global natural gas portfolio across Argentina and the Mediterranean to meet rising demand from buyers seeking energy security amid persistent disruptions in West Asia, according to Freeman Shaheen, the company’s president of global gas.
Global gas markets have absorbed two major supply shocks over the past four years. The 2022 Ukraine war and recent conflicts involving Iran have cut off major pipeline and liquefied natural gas supplies from top producers Russia and Qatar, driving prices upward.
“What we’re seeing from this crisis is that it just reinforces the need for diversity – diversity of supply and diversity of different contracting structures,” Shaheen said in an interview with Reuters on the sidelines of the Gastech conference in Bangkok, adding that buyers want to avoid overexposure to illiquid spot markets.
LNG Supply Capacity and Global Expansion Targets
Chevron currently commands roughly 20 million metric tons per annum of LNG supply capacity. According to company figures, this total combines 16 million tons of net gas production from its operated assets with 4 million tons contracted from the US Gulf Coast, which commenced operations in February and will ramp up over the coming years.
To grow this footprint, Chevron is evaluating upstream and midstream prospects in South America and southern Europe. Shaheen pointed to Argentina as a high-potential market for crude and gas development, while identifying the East Mediterranean as an increasingly vital region for future supply.
Those expansion efforts extend globally, with Shaheen noting that Africa and Australia remain under consideration. However, he emphasized that any new commitments depend strictly on securing favorable capital, fiscal, and regulatory terms.
Venezuela Investments and Portfolio Competition
Global portfolio additions are weighed directly against active projects in other heavy-capital regions, most notably Venezuela. Chevron and its joint-venture partners are weighing capital allocations designed to more than double oil output in Venezuela to over $7 billion by 2031.
“I’ve been hearing that Venezuela has a lot of capital that’s going to have to go that way coming up,” Shaheen told Reuters. “Everything is got to get analysed in our project queue and it gets ranked.”
In the Mediterranean, Chevron cemented its regional footprint in June by winning regulatory approval to operate and lead gas exploration in an offshore block off Greece.
Meanwhile, in its established operating base in Australia, Chevron operates the Gorgon and Wheatstone LNG projects, which supply key Asian markets. Japan remains the anchor market for Australian volumes, alongside structural supply agreements into Singapore, China, and South Korea. In Singapore, Chevron signed an agreement in 2024 to supply Sembcorp Industries with up to 0.6 million tons per annum of LNG starting in 2028.
Shifting Contracting Models and Asian Demand
The recent geopolitical instability has altered how state-backed importers secure long-term energy supplies. Rather than relying on traditional government-to-government arrangements, buyers increasingly favor direct contracts with large portfolio suppliers.
When asked about expanding into South Asia, Shaheen indicated that India remains an attractive target despite current pricing sensitivities. “I’d love to have a deal in India,” Shaheen said. “It’s just they’re very, very headline-price driven. I think India is still evolving. There’s going to be great opportunities over time.”
Keep reading
- Science Tokyo and MIT Launch 3-Year Partnership for Research and Education
- X Corp and SpaceXAI Drop Antitrust Claims Against Apple, Continue Suit Against OpenAI
- FeSMC-UGT Madrid and State Security Sector Submit Proposal to Contracting Board (archyde.com)
- Breakthrough Salk Study Uncovers Mechanism Behind Immunotherapy Resistance: Interferons, Mitochondrial Dysfunction, and PGE2″ Interferons, mitochondrial dysfunction and PGE2: Salk study reveals mechanism behind immunotherapy resistance. Boost its search engine visibility with relevant keywords for maximum impact. Immunotherapy resistance remains one of the biggest hurdles in cancer treatment. According to a recent study published in the journal Nature Communications, scientists at the Salk Institute have made a groundbreaking discovery that sheds light on the underlying mechanisms behind this resistance. The study reveals that interferons, a type of protein that plays a crucial role in the immune system, can contribute to mitochondrial dysfunction in cancer cells. This dysfunction can lead to the production of prostaglandin E2 (PGE2), a molecule that promotes tumor growth and resistance to immunotherapy. In their study, the researchers found that PGE2 production was a key factor in the development of immunotherapy resistance in cancer cells. The team used a combination of experimental and computational models to investigate the relationship between interferons, mitochondrial dysfunction, and PGE2 production. The findings of the study suggest that targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance. The researchers propose that blocking PGE2 receptors or inhibiting its production could help restore the function of mitochondria in cancer cells, making them more susceptible to immunotherapy. The study’s authors hope that their findings will pave the way for the development of new therapies that can overcome immunotherapy resistance and improve treatment outcomes for cancer patients. Key Takeaways: – Interferons contribute to mitochondrial dysfunction in cancer cells – Mitochondrial dysfunction leads to PGE2 production, promoting tumor growth and resistance to immunotherapy – Targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance – Restoring mitochondrial function in cancer cells could make them more susceptible to immunotherapy Keywords: immunotherapy resistance, interferons, mitochondrial dysfunction, PGE2, Salk Institute, cancer treatment, breakthrough study, Nature Communications. (archyworldys.com)